Limited coverage criteria – voriconazole

Last updated on March 24, 2025

Special Authority requests can now be submitted online. It's simple and quick!

Learn more or log in

Return to Special Authority drug list

Generic name	voiconazole
Strength & form	50 mg, 200 mg tablet 200 mg injection

Generic name

voiconazole

Strength & form

50 mg, 200 mg tablet

200 mg injection

Special Authority criteria	Approval period
For continuation of hospital-initiated treatment of invasive aspergillosis OR For continuation of hospital-initiated treatment of culture-proven invasive candidiasis with documented resistance to fluconazole	3 months

Special Authority criteria

Approval period

For continuation of hospital-initiated treatment of invasive aspergillosis

For continuation of hospital-initiated treatment of culture-proven invasive candidiasis with documented resistance to fluconazole

3 months

Practitioner exemptions

None

Special notes

PharmaCare does not provide coverage for community-initiated treatment of invasive aspergillosis associated with HIV

Special Authority request form(s)

Log in to eForms
HLTH 5328 – General Special Authority request (PDF, 656KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics